These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 18325679)

  • 1. Phase I-II study of intraoperative radiation therapy (IORT) after radical prostatectomy for prostate cancer.
    Saracino B; Gallucci M; De Carli P; Soriani A; Papalia R; Marzi S; Landoni V; Petrongari MG; Arcangeli S; Forastiere E; Sentinelli S; Arcangeli G
    Int J Radiat Oncol Biol Phys; 2008 Jul; 71(4):1049-56. PubMed ID: 18325679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Need for high radiation dose (>or=70 gy) in early postoperative irradiation after radical prostatectomy: a single-institution analysis of 334 high-risk, node-negative patients.
    Cozzarini C; Montorsi F; Fiorino C; Alongi F; Bolognesi A; Da Pozzo LF; Guazzoni G; Freschi M; Roscigno M; Scattoni V; Rigatti P; Di Muzio N
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):966-74. PubMed ID: 19619960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conformal radiotherapy for detectable PSA following radical prostatectomy: efficacy and predictive factors of recurrence.
    Delongchamps NB; Zerbib M; Mejean A; Rouach Y; Debre B; Peyromaure M
    Can J Urol; 2009 Oct; 16(5):4813-9. PubMed ID: 19796456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved outcomes with higher doses for salvage radiotherapy after prostatectomy.
    King CR; Spiotto MT
    Int J Radiat Oncol Biol Phys; 2008 May; 71(1):23-7. PubMed ID: 18207668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Achieving an undetectable PSA after radiotherapy for biochemical progression after radical prostatectomy is an independent predictor of biochemical outcome--results of a retrospective study.
    Wiegel T; Lohm G; Bottke D; Höcht S; Miller K; Siegmann A; Schostak M; Neumann K; Hinkelbein W
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1009-16. PubMed ID: 18963539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraoperative radiotherapy during radical prostatectomy for intermediate-risk to locally advanced prostate cancer: treatment technique and evaluation of perioperative and functional outcome vs standard radical prostatectomy, in a matched-pair analysis.
    Rocco B; Jereczek-Fossa BA; Matei DV; Verweij F; Santoro L; Vavassori A; Ospina JC; Cedeira F; Ciocca M; Orecchia R; de Cobelli O
    BJU Int; 2009 Dec; 104(11):1624-30. PubMed ID: 19624597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salvage hypofractionated radiotherapy for biochemically recurrent prostate cancer after radical prostatectomy.
    Wong GW; Palazzi-Churas KL; Jarrard DF; Paolone DR; Graf AK; Hedican SP; Wegenke JD; Ritter MA
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):449-55. PubMed ID: 17869014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase I trial of pre-operative radiotherapy for prostate cancer: clinical and translational studies.
    Supiot S; Shubbar S; Fleshner N; Warde P; Hersey K; Wallace K; Cole H; Sweet J; Tsihlias J; Jewett MA; Klotz L; Bristow RG
    Radiother Oncol; 2008 Jul; 88(1):53-60. PubMed ID: 18423916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraoperative radiotherapy during radical prostatectomy for locally advanced prostate cancer: technical and dosimetric aspects.
    Krengli M; Terrone C; Ballarè A; Loi G; Tarabuzzi R; Marchioro G; Beldì D; Mones E; Bolchini C; Volpe A; Frea B
    Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):1073-7. PubMed ID: 19625135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical results of radical prostatectomy for patients with prostate cancer in Macau.
    Ho SF; Lao HF; Li K; Tse MK
    Chin Med J (Engl); 2008 Feb; 121(4):295-8. PubMed ID: 18304459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncological control after radical prostatectomy in men with clinical T3 prostate cancer: a single-centre experience.
    Xylinas E; Drouin SJ; Comperat E; Vaessen C; Renard-Penna R; Misrai V; Bitker MO; Chartier-Kastler E; Richard F; Cussenot O; Roupret M
    BJU Int; 2009 May; 103(9):1173-8; discussion 1178. PubMed ID: 19040530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgery versus implant for early prostate cancer: results from a single institution, 1992-2005.
    Colberg JW; Decker RH; Khan AM; McKeon A; Wilson LD; Peschel RE
    Cancer J; 2007; 13(4):229-32. PubMed ID: 17762756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncologic outcome and patterns of recurrence after salvage radical prostatectomy.
    Paparel P; Cronin AM; Savage C; Scardino PT; Eastham JA
    Eur Urol; 2009 Feb; 55(2):404-10. PubMed ID: 18639970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02/AUO AP 09/95.
    Wiegel T; Bottke D; Steiner U; Siegmann A; Golz R; Störkel S; Willich N; Semjonow A; Souchon R; Stöckle M; Rübe C; Weissbach L; Althaus P; Rebmann U; Kälble T; Feldmann HJ; Wirth M; Hinke A; Hinkelbein W; Miller K
    J Clin Oncol; 2009 Jun; 27(18):2924-30. PubMed ID: 19433689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Salvage radiotherapy for pT3 prostate cancer with PSA failure after radical prostatectomy].
    Wakita T; Hayashi N; Fuwa N
    Hinyokika Kiyo; 2005 Sep; 51(9):575-80. PubMed ID: 16229369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility and preliminary outcome of salvage combined HDR brachytherapy and external beam radiotherapy (EBRT) for local recurrences after radical prostatectomy.
    Niehoff P; Loch T; Nürnberg N; Galalae R; Egberts J; Kohr P; Kovács G
    Brachytherapy; 2005; 4(2):141-5. PubMed ID: 15893268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term results of conformal radiotherapy for prostate cancer: impact of dose escalation on biochemical tumor control and distant metastases-free survival outcomes.
    Zelefsky MJ; Yamada Y; Fuks Z; Zhang Z; Hunt M; Cahlon O; Park J; Shippy A
    Int J Radiat Oncol Biol Phys; 2008 Jul; 71(4):1028-33. PubMed ID: 18280056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postoperative radiotherapy after radical prostatectomy for prostate carcinoma: the experience of the Brescia Radium Institute.
    Caraffini B; De Stefani A; Vitali E; Magri E; Tonoli S; Frata P; Gatta R; Magrini SM
    Radiol Med; 2006 Aug; 111(5):741-7. PubMed ID: 16721508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sooner or later? Outcome analysis of 431 prostate cancer patients treated with postoperative or salvage radiotherapy.
    Jereczek-Fossa BA; Zerini D; Vavassori A; Fodor C; Santoro L; Minissale A; Cambria R; Cattani F; Garibaldi C; Serafini F; Matei VD; de Cobelli O; Orecchia R
    Int J Radiat Oncol Biol Phys; 2009 May; 74(1):115-25. PubMed ID: 19004572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results of three dimensional conformal radiotherapy and hormonal therapy for local recurrence after radical prostatectomy.
    Schwarz R; Krüll A; Tribius S; Alberti W
    Strahlenther Onkol; 2005 Jul; 181(7):442-7. PubMed ID: 15995837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.